UTI Core Equity Fund Direct Growth

Fund Overview

Fund Size

₹6,220 Cr

Expense Ratio

1.08%

ISIN

INF789F01UG3

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

01 Jan 2013

About this fund

UTI Core Equity Fund Direct Growth is a Large & Mid-Cap mutual fund schemes offered by UTI Mutual Fund. This fund has been in existence for 13 years, 9 months and 11 days, having been launched on 01-Jan-13.
As of 09-Oct-26, it has a Net Asset Value (NAV) of ₹187.81, Assets Under Management (AUM) of 6219.89 Crores, and an expense ratio of 1.08%.

UTI Core Equity Fund Direct Growth has given a CAGR return of 13.86% since inception.
The fund's asset allocation comprises around 97.97% in equities, 0.00% in debts, and 2.03% in cash & cash equivalents.
You can start investing in UTI Core Equity Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

-2.43%

— (Cat Avg.)

3 Years

+13.39%

+12.13% (Cat Avg.)

5 Years

+12.39%

+10.55% (Cat Avg.)

10 Years

+13.29%

+12.85% (Cat Avg.)

Since Inception

+13.86%

— (Cat Avg.)

Portfolio Summaryas of 30th September 2026

Equity	₹6,093.78 Cr	97.97%
Others	₹126.11 Cr	2.03%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
HDFC Bank Ltd	Equity	₹340.86 Cr	5.48%
ICICI Bank Ltd	Equity	₹283.18 Cr	4.55%
Reliance Industries Ltd	Equity	₹232.89 Cr	3.74%
Infosys Ltd	Equity	₹181.11 Cr	2.91%
State Bank of India	Equity	₹180.96 Cr	2.91%
ITC Ltd	Equity	₹178.01 Cr	2.86%
Larsen & Toubro Ltd	Equity	₹170.88 Cr	2.75%
Aurobindo Pharma Ltd	Equity	₹163.73 Cr	2.63%
Hero MotoCorp Ltd	Equity	₹145.14 Cr	2.33%
Power Grid Corp Of India Ltd	Equity	₹143.66 Cr	2.31%
Aditya Birla Capital Ltd	Equity	₹141.99 Cr	2.28%
Info Edge (India) Ltd	Equity	₹124.84 Cr	2.01%
Bharti Airtel Ltd	Equity	₹119.63 Cr	1.92%
Net Current Assets	Cash	₹117.82 Cr	1.89%
Sundaram Finance Ltd	Equity	₹114.77 Cr	1.85%
General Insurance Corp of India	Equity	₹110.19 Cr	1.77%
Phoenix Mills Ltd	Equity	₹107.75 Cr	1.73%
Life Insurance Corporation of India	Equity	₹104.57 Cr	1.68%
Motilal Oswal Financial Services Ltd	Equity	₹103.53 Cr	1.66%
Wipro Ltd	Equity	₹101.72 Cr	1.64%
Indus Towers Ltd Ordinary Shares	Equity	₹97.02 Cr	1.56%
Coal India Ltd	Equity	₹96.23 Cr	1.55%
Grasim Industries Ltd	Equity	₹95.49 Cr	1.54%
Embassy Office Parks REIT	Equity - REIT	₹94.17 Cr	1.51%
Oil & Natural Gas Corp Ltd	Equity	₹93.53 Cr	1.50%
UPL Ltd	Equity	₹92.62 Cr	1.49%
Dr Reddy's Laboratories Ltd	Equity	₹91.15 Cr	1.47%
The Federal Bank Ltd	Equity	₹85.85 Cr	1.38%
Vedanta Aluminium Metal Ltd	Equity	₹84.15 Cr	1.35%
Shriram Finance Ltd	Equity	₹83.49 Cr	1.34%
Ajanta Pharma Ltd	Equity	₹82.79 Cr	1.33%
InterGlobe Aviation Ltd	Equity	₹79.21 Cr	1.27%
Mahindra & Mahindra Ltd	Equity	₹76.53 Cr	1.23%
Bagmane Prime Office REIT Units	Equity - REIT	₹75.29 Cr	1.21%
ICICI Life Insurance Ltd	Equity	₹69.62 Cr	1.12%
HCL Technologies Ltd	Equity	₹68.97 Cr	1.11%
Caplin Point Laboratories Ltd	Equity	₹67.43 Cr	1.08%
Oracle Financial Services Software Ltd	Equity	₹66.93 Cr	1.08%
GHCL Ltd	Equity	₹65.77 Cr	1.06%
DCM Shriram Ltd	Equity	₹64.74 Cr	1.04%
VRL Logistics Ltd	Equity	₹64.47 Cr	1.04%
Emami Ltd	Equity	₹63.84 Cr	1.03%
Tata Power Co Ltd	Equity	₹63.22 Cr	1.02%
G R Infraprojects Ltd	Equity	₹62.4 Cr	1.00%
IndusInd Bank Ltd	Equity	₹62.2 Cr	1.00%
Bank of Maharashtra	Equity	₹61.98 Cr	1.00%
Crompton Greaves Consumer Electricals Ltd	Equity	₹61.9 Cr	1.00%
Jubilant Foodworks Ltd	Equity	₹61.12 Cr	0.98%
NIIT Learning Systems Ltd	Equity	₹61.07 Cr	0.98%
National Aluminium Co Ltd	Equity	₹59.78 Cr	0.96%
Suzlon Energy Ltd	Equity	₹55.29 Cr	0.89%
Colgate-Palmolive (India) Ltd	Equity	₹54.97 Cr	0.88%
JK Paper Ltd	Equity	₹50.85 Cr	0.82%
Max Financial Services Ltd	Equity	₹47.86 Cr	0.77%
Multi Commodity Exchange of India Ltd	Equity	₹47.53 Cr	0.76%
Great Eastern Shipping Co Ltd	Equity	₹46.69 Cr	0.75%
Raymond Lifestyle Ltd	Equity	₹46.37 Cr	0.75%
Marksans Pharma Ltd	Equity	₹45.22 Cr	0.73%
Alembic Pharmaceuticals Ltd	Equity	₹43.93 Cr	0.71%
Biocon Ltd	Equity	₹43.88 Cr	0.71%
Tata Motors Ltd	Equity	₹40.98 Cr	0.66%
REC Ltd	Equity	₹37.91 Cr	0.61%
Glenmark Pharmaceuticals Ltd	Equity	₹35.66 Cr	0.57%
Balkrishna Industries Ltd	Equity	₹34.72 Cr	0.56%
Petronet LNG Ltd	Equity	₹31.86 Cr	0.51%
Tips Music Ltd	Equity	₹31.39 Cr	0.50%
National Stock Exchange of India Ltd	Equity	₹28.8 Cr	0.46%
Mahindra Holidays & Resorts India Ltd	Equity	₹27.59 Cr	0.44%
Maharashtra Seamless Ltd	Equity	₹16.13 Cr	0.26%
Rossari Biotech Ltd Ordinary Shares	Equity	₹16.07 Cr	0.26%
Axis Bank Ltd. Std - Margin	Cash - Repurchase Agreement	₹7 Cr	0.11%
Vedanta Iron and Steel Ltd	Equity	₹6.58 Cr	0.11%
Clearing Corporation Of India Ltd. Std - Margin	Cash - Repurchase Agreement	₹1.29 Cr	0.02%
Vedanta Power Ltd	Equity	₹1.1 Cr	0.02%

Allocation By Market Cap (Equity)

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Financial Services	₹1,905.32 Cr	30.63%
Healthcare	₹573.79 Cr	9.22%
Industrials	₹543.67 Cr	8.74%
Consumer Cyclical	₹494.36 Cr	7.95%
Basic Materials	₹487.44 Cr	7.84%
Energy	₹454.51 Cr	7.31%
Technology	₹418.74 Cr	6.73%
Communication Services	₹372.87 Cr	5.99%
Consumer Defensive	₹357.89 Cr	5.75%
Utilities	₹207.99 Cr	3.34%
Real Estate	₹107.75 Cr	1.73%

Risk & Performance Ratios

Fund Managers

V Srivatsa

Since May 2017

Additional Scheme Detailsas of 30th September 2026

ISIN

INF789F01UG3

Expense Ratio

1.08%

Exit Load

1.00%

Fund Size

₹6,220 Cr

Age

13 years 9 months

Lumpsum Minimum

₹5,000

Fund Status

Open Ended Investment Company

Benchmark

Nifty LargeMidcap 250 TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Large & Mid-Cap Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Abakkus Large & Mid Cap Fund Regular Growth Very High Risk	2.4%	0.0%	₹437.16 Cr	-
Abakkus Large & Mid Cap Fund Direct Growth Very High Risk	0.9%	0.0%	₹437.16 Cr	-
TRUSTMF Large & Mid Cap Fund Regular Growth Very High Risk	5.8%	1.0%	₹365.69 Cr	-
TRUSTMF Large & Mid Cap Fund Direct Growth Very High Risk	4.1%	1.0%	₹365.69 Cr	-
The Wealth Company Large & Mid Cap Fund Direct Growth Very High Risk	3.1%	1.0%	₹111.43 Cr	-
The Wealth Company Large & Mid Cap Fund Regular Growth Very High Risk	5.1%	1.0%	₹111.43 Cr	-
Edelweiss Nifty LargeMidcap 250 ETF Very High Risk	1.2%	-	₹163.19 Cr	-4.9%
JM Large & Mid Cap Fund Direct Growth Very High Risk	1.0%	1.0%	₹464.46 Cr	-0.1%
JM Large & Mid Cap Fund Regular Growth Very High Risk	2.7%	1.0%	₹464.46 Cr	-1.8%
Samco Large & Mid Cap Fund Direct Growth Very High Risk	2.3%	1.0%	₹98.58 Cr	-6.8%
Samco Large & Mid Cap Fund Regular Growth Very High Risk	3.8%	1.0%	₹98.58 Cr	-8.3%
Mirae Asset BSE 200 Equal Weight ETF Very High Risk	0.5%	-	₹19.92 Cr	-2.3%
Groww Nifty 200 ETF Very High Risk	0.4%	-	₹16.47 Cr	-6.6%
Helios Large & Mid Cap Fund Direct Growth Very High Risk	1.0%	1.0%	₹1473.18 Cr	0.1%
Helios Large & Mid Cap Fund Regular Growth Very High Risk	2.6%	1.0%	₹1473.18 Cr	-1.5%
ITI Large & Mid Cap Fund Regular Growth Very High Risk	2.6%	0.0%	₹728.59 Cr	-0.9%
ITI Large & Mid Cap Fund Direct Growth Very High Risk	1.1%	0.0%	₹728.59 Cr	0.8%
Bajaj Finserv Large and Mid Cap Fund Direct Growth Low Risk	1.2%	1.0%	₹2463.06 Cr	-2.2%
Bajaj Finserv Large and Mid Cap Fund Regular Growth Low Risk	2.6%	1.0%	₹2463.06 Cr	-3.6%
PGIM India Large and Mid Cap Fund Regular Growth Very High Risk	2.5%	0.0%	₹830.84 Cr	-4.9%
PGIM India Large and Mid Cap Fund Direct Growth Very High Risk	0.9%	0.0%	₹830.84 Cr	-3.3%
WhiteOak Capital Large & Mid Cap Fund Direct Growth Very High Risk	0.9%	0.0%	₹2524.36 Cr	-0.0%
WhiteOak Capital Large & Mid Cap Fund Regular Growth Very High Risk	2.4%	0.0%	₹2524.36 Cr	-1.5%
LIC MF Large & Mid Cap Fund Direct Growth Very High Risk	1.7%	1.0%	₹3198.49 Cr	-3.2%
LIC MF Large & Mid Cap Fund Regular Growth Very High Risk	2.9%	1.0%	₹3198.49 Cr	-4.4%
Mirae Asset Emerging Bluechip Direct Growth Very High Risk	0.9%	1.0%	₹45811.35 Cr	-2.6%
HDFC Large and Mid Cap Fund Regular Growth Very High Risk	1.6%	1.0%	₹30294.02 Cr	-4.8%
Kotak Equity Opportunities Fund Direct Growth Very High Risk	0.7%	1.0%	₹32325.48 Cr	-4.0%
HDFC Large and Mid Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹30294.02 Cr	-4.1%
Quant Large and Mid Cap Fund Regular Growth Very High Risk	2.5%	1.0%	₹3487.47 Cr	5.0%
ICICI Prudential Large & Mid Cap Fund Direct Growth Very High Risk	1.3%	1.0%	₹33591.78 Cr	-5.6%
Bandhan Core Equity Fund Direct Growth Very High Risk	1.2%	1.0%	₹21020.50 Cr	0.2%
Invesco India Growth Opportunities Fund Direct Growth Very High Risk	0.8%	1.0%	₹12387.43 Cr	3.5%
Nippon India Vision Fund Direct Growth Very High Risk	1.5%	1.0%	₹7903.50 Cr	-4.2%
Edelweiss Large & Mid Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹4942.29 Cr	-0.5%
Mahindra Manulife Large & Mid Cap Fund Regular Growth Very High Risk	2.2%	1.0%	₹2929.22 Cr	-0.9%
Mahindra Manulife Large & Mid Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹2929.22 Cr	0.5%
Sundaram large and Mid Cap Fund Regular Growth Very High Risk	2.4%	1.0%	₹7543.73 Cr	2.0%
Motilal Oswal Large and Midcap Fund Regular Growth Very High Risk	1.9%	1.0%	₹20159.10 Cr	3.2%
Motilal Oswal Large and Midcap Fund Direct Growth Very High Risk	0.9%	1.0%	₹20159.10 Cr	4.3%
Invesco India Growth Opportunities Fund Regular Growth Very High Risk	1.9%	1.0%	₹12387.43 Cr	2.3%
Edelweiss Large & Mid Cap Fund Regular Growth Very High Risk	1.1%	1.0%	₹4942.29 Cr	-1.8%
Mirae Asset Emerging Bluechip Regular Growth Very High Risk	1.8%	1.0%	₹45811.35 Cr	-3.5%
UTI Core Equity Fund Direct Growth Very High Risk	1.1%	1.0%	₹6219.89 Cr	-2.4%
Aditya Birla Sun Life Equity Advantage Fund Direct Growth Very High Risk	1.3%	1.0%	₹5997.92 Cr	0.3%
Bank of India Large & Mid Cap Equity Fund Direct Growth Very High Risk	1.5%	1.0%	₹529.09 Cr	1.9%
Canara Robeco Emerging Equities Direct Growth Very High Risk	0.8%	1.0%	₹24578.35 Cr	-5.1%
SBI Large & Midcap Fund Direct Growth Very High Risk	0.8%	0.0%	₹42335.63 Cr	-1.9%
Sundaram large and Mid Cap Fund Direct Growth Very High Risk	1.4%	1.0%	₹7543.73 Cr	3.1%
Tata Large & Mid Cap Fund Direct Growth Very High Risk	0.8%	0.0%	₹7679.32 Cr	-9.1%

About the AMC

UTI Mutual Fund

+91-22-6678 6666

https://www.utimf.com/

Total AUM

₹3,71,805 Cr

Address

UTI Towers, Gn Block, Mumbai, 400 051

Other Funds by UTI Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
UTI BSE India Sector Leaders Index Fund Direct Growth Very High Risk	-	0.0%	-	-
UTI Balanced Hybrid Fund Direct Growth Moderately High risk	-	1.0%	-	-
UTI Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	₹101.72 Cr	-
UTI Liquid Fund Direct Growth Moderate Risk	0.2%	0.0%	₹31556.43 Cr	6.6%
UTI Nifty500 Shariah Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹87.67 Cr	-
UTI Children's Equity Fund Direct Growth Very High Risk	1.3%	0.0%	₹1063.07 Cr	-9.5%
UTI Multi Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹2112.99 Cr	-0.6%
UTI Income Plus Arbitrage Active Fund of Fund Direct Growth Moderately High risk	0.2%	0.0%	₹165.77 Cr	5.3%
UTI Nifty India Manufacturing Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹30.61 Cr	-0.1%
UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund Direct Growth Very High Risk	0.9%	0.0%	₹130.10 Cr	2.8%
UTI Quant Fund Direct Growth Very High Risk	0.6%	1.0%	₹1361.09 Cr	-4.8%
UTI Nifty Alpha Low-Volatility 30 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹63.43 Cr	-6.9%
UTI Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹75.94 Cr	-0.1%
UTI Nifty Private Bank Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹226.20 Cr	-1.1%
UTI Nifty200 Quality 30 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹500.14 Cr	-8.4%
UTI Innovation Fund Direct Growth Very High Risk	1.1%	1.0%	₹767.83 Cr	-7.1%
UTI Fixed Income Interval Fund Annual Plan I Direct Growth Low Risk	-	0.0%	₹13.13 Cr	5.2%
UTI Fixed Term Income Fund - Series XXXV-I (1260 Days) Direct Growth Low Risk	-	0.0%	₹316.65 Cr	6.0%
UTI Fixed Term Income Fund - Series XXXV-III (1176 Days) Direct Growth Low to Moderate Risk	-	0.0%	₹42.79 Cr	6.0%
UTI FIIF Ser 2 Qt Interval V Direct Growth Low Risk	-	1.0%	₹2.20 Cr	6.3%
UTI Fixed Income Interval Fund Quarterly I Direct Growth Low Risk	-	0.0%	₹9.74 Cr	6.5%
UTI Fixed Inc Intvl Series2 Qt Intvl VI Direct Growth Moderate Risk	-	1.0%	₹8.54 Cr	6.8%
UTI-Fixed Term Income Fund - Series XXX-VI (1107 days) Direct Growth Low to Moderate Risk	-	0.0%	-	10.0%
UTI-Fixed Term Income Fund - Series XXX - VII (1294 days) Direct Growth Low to Moderate Risk	-	0.0%	-	-
UTI Fixed Term Income Fund - Series XXXV-II (1223 Days) Direct Growth Low Risk	-	-	₹176.51 Cr	6.1%
UTI Fixed Income Interval Fund Annual Plan III Direct Growth Low to Moderate Risk	-	0.0%	₹13.38 Cr	6.9%
UTI Fixed Term Income Fund - Series XXXVI-I (1574 days) Direct Growth Low to Moderate Risk	-	0.0%	₹57.60 Cr	5.5%
UTI Floater Fund Direct Growth Low to Moderate Risk	0.4%	0.0%	₹1519.41 Cr	6.0%
UTI Nifty 500 Value 50 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹838.01 Cr	2.4%
UTI Banking & PSU Debt Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹1450.05 Cr	6.0%
UTI Focused Equity Fund Direct Growth Very High Risk	1.0%	1.0%	₹2310.08 Cr	-5.7%
UTI Silver ETF Fund of Fund Direct Growth Very High Risk	0.1%	1.0%	₹634.31 Cr	31.4%
UTI Nifty200 Momentum 30 Index Fund Direct Growth Very High Risk	1.0%	0.0%	₹7961.68 Cr	-5.8%
UTI Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹5647.53 Cr	5.3%
UTI Corporate Bond Fund Direct Growth Moderate Risk	0.3%	0.0%	₹4688.73 Cr	4.6%
UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹249.13 Cr	-6.2%
UTI Arbitrage Fund Direct Growth Low Risk	1.3%	0.0%	₹11131.60 Cr	6.6%
UTI Small Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹5229.11 Cr	2.9%
UTI Ultra Short Term Fund Direct Growth Moderate Risk	0.4%	0.0%	₹3684.90 Cr	6.7%
UTI Credit Risk Fund Direct Growth Moderately High risk	1.0%	1.0%	₹249.38 Cr	6.1%
UTI Dividend Yield Fund Direct Growth Very High Risk	1.4%	1.0%	₹3581.66 Cr	-5.8%
UTI Banking and Financial Services Fund Direct Growth Very High Risk	1.4%	1.0%	₹1339.13 Cr	-0.5%
UTI Dynamic Bond Fund Direct Growth Moderate Risk	0.9%	0.0%	₹398.38 Cr	4.5%
UTI Hybrid Equity Fund Direct Growth Very High Risk	1.3%	1.0%	₹6474.74 Cr	-3.7%
UTI Long Term Equity Fund Direct Growth Very High Risk	1.0%	0.0%	₹3253.23 Cr	-7.6%
UTI Flexi Cap Fund Direct Growth Very High Risk	1.1%	1.0%	₹22495.18 Cr	-4.5%
UTI Bond Fund Direct Growth Moderately High risk	1.3%	0.0%	₹303.90 Cr	2.9%
UTI Liquid Fund Cash Plan Direct Growth Moderate Risk	0.2%	0.0%	₹33248.42 Cr	6.4%
UTI Gilt Fund Direct Growth Moderate Risk	0.7%	0.0%	₹414.87 Cr	4.0%
UTI India Consumer Fund Direct Growth Very High Risk	1.6%	1.0%	₹678.01 Cr	-8.4%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of UTI Core Equity Fund Direct Growth?

The NAV of UTI Core Equity Fund Direct Growth, as of 09-Oct-2026, is ₹187.81.

What are the returns of UTI Core Equity Fund Direct Growth?

The fund has generated -2.43% over the last 1 year and 13.39% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of UTI Core Equity Fund Direct Growth?

The fund's allocation of assets is distributed as 97.97% in equities, 0.00% in bonds, and 2.03% in cash and cash equivalents.

Who manages the UTI Core Equity Fund Direct Growth?

The fund managers responsible for UTI Core Equity Fund Direct Growth are:-

V Srivatsa

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

UTI Core Equity Fund Direct Growth

Fund Overview